No hay productos en el carrito



Defining Optimal Immunotherapies for Type 1 Diabetes: (…) Vol. 292
NOVARTIS FOUNDATION
1ª Edición Agosto 2008
Inglés
Tapa dura
304 pags
0null x null x null cm
ISBN 9780470723258
Editorial WILEY
LIBRO IMPRESO
-5%
193,94 €184,24 €IVA incluido
186,48 €177,15 €IVA no incluido
Recíbelo en un plazo de
2 - 3 semanas
LIBRO ELECTRÓNICO
-5%
168,47 €160,05 €IVA incluido
161,99 €153,89 €IVA no incluido
Acceso On Line
Inmediato
This book is a comprehensive and up-to-date account of where we stand in immunological
strategies for preventing or treating type 1 diabetes (T1D).
* Brings together contributions from the leaders in the arena of clinical immunotherapy,
not limited to the diabetes field exclusively, in order to delineate a road-map
that would lead to future clinical trials.
* The book integrates information from human and animal studies.
* The book considers T1D within the broader context of autoimmune disease.
* The format contains several discussions, which address specific questions
and provides guidelines for future strategies and solutions for discovering
a cure.
TABLE OF CONTENTS
1. Michael Rutter
Introduction: whither gene–environment interactions?
2. Rudolf Uher
Gene–environment interaction: overcoming methodological challenges
Discussion
3. Marco Battaglia, Cecilia Marino, Michel Maziade, Massimo Molteni and Francesca
D’Amato
Gene–environment interaction and behavioural disorders: a developmental
perspective based on endophenotypes
Discussion
4. Naomi R. Wray, William L. Coventry, Michael R. James, Grant W. Montgomery,
Lindon J. Eaves and Nicholas G. Martin
Use of monozygotic twins to investigate the relationship between 5HTTLPR genotype,
depression and stressful life events: an application of Item Response Theory
Discussion
Appendix
General discussion I
5. Harold Snieder, Xiaoling Wang, Vasiliki Lagou, Brenda W. J. H. Penninx,
Harriëtte Riese and Catharina A. Hartman
Role of gene–stress interactions in gene-finding studies
Discussion
6. Kenneth A. Dodge
Practice and public policy in the era of gene–environment interactions
Discussion
7. Kristi B. Adamo and Frédérique Tesson
Gene–environment interaction and the metabolic syndrome
Discussion
General discussion II
8. Stephen P. Robertson and Richie Poulton
Longitudinal studies of gene–environment interaction in common diseases—good
value for money?
Discussion
9. Kee-Seng Chia
Gene–environment interactions in breast cancer
Discussion
10. Malak Kotb, Nourtan Abdeltawab, Ramy Aziz, Sarah Rowe, Robert W. Williams
and Lu Lu
Unbiased forward genetics and systems biology approaches to understanding how
gene–environment interactions work to predict susceptibility and outcomes
of infections
Discussion
11. Steven R. Kleeberger and Hye-Youn Cho
Gene–environment interactions in environmental lung diseases
Discussion
General discussion III
12. Fernando D. Martinez
Gene–environment interaction in complex diseases: asthma as an illustrative
case
Discussion
13. Michael Rutter
Conclusions: taking stock and looking ahead
Glossary
Index of contributors
Subject index
© 2025 Axón Librería S.L.
2.149.0